In this regard, in the study conducted by Stubbs et al., 2010, on the seven ESRD patients with vitamin D insufficiency, paricalcitol administration did not lead to a significant change in the levels of TNF-a and IL-6 biomarkers [39], although this study did not report CRP changes. The gene discussed is IL6; the disease is vitamin D deficiency.